A safety data sheet (SDS) is a standardized hazard communication document that a manufacturer or supplier prepares for a chemical substance. It tells anyone who handles, ships, stores or disposes of that substance what precautions to take. It is not a laboratory report, it contains no measurement taken from the vial you received, and it says nothing about whether the material inside matches the label. Understanding that distinction is one of the more useful pieces of document literacy a research buyer can acquire.
What is a safety data sheet, and who is it written for?
An SDS is written for occupational safety. Its intended readers are laboratory personnel, warehouse and transport workers, waste handlers and emergency responders. Under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), which most major jurisdictions have adopted into their own regulations, an SDS follows a fixed sixteen section structure, so that a responder can find the same category of information in the same place for any chemical.
The document answers questions such as: how should this material be stored, what protective equipment is appropriate, what should be done if it is spilled or if a fire occurs, and how should it be classified for transport. Those are legitimate and important questions. They are simply different questions from the ones a research buyer is usually trying to answer, which are questions of identity, purity and batch provenance. Research peptides are supplied for research use only, and an SDS supports safe handling in that setting, nothing more.
What is actually inside a peptide SDS?
The sixteen sections cover, in order: identification of the product and supplier, hazard identification, composition and information on ingredients, first aid measures, firefighting measures, accidental release measures, handling and storage, exposure controls and personal protection, physical and chemical properties, stability and reactivity, toxicological information, ecological information, disposal considerations, transport information, regulatory information, and other information.
Read one for a research peptide and a pattern appears quickly. The composition section restates the substance name and, where one exists, a CAS registry number, as claimed by the supplier. The physical properties section often describes appearance and solubility in general terms. The toxicological and ecological sections frequently read "no data available", because most research peptides have not been characterized in the standardized studies that the format anticipates. An SDS is therefore largely a document of declarations and precautionary statements, assembled around the identity that the supplier asserts.
Why does an SDS prove nothing about the batch in your vial?
Because an SDS is authored, not measured. Nothing in it originates from an instrument that analysed your material. It carries no lot number, no date of analysis, no named laboratory, no chromatogram and no mass spectrum. The same file is normally attached to every unit of a product a vendor sells, across every synthesis run, for years.
That matters because batch level variation is exactly what laboratory evidence exists to detect. Two lots of the same peptide can differ in purity, in impurity profile, in residual solvent and counter-ion content, and in whether the molecule is the one named on the label at all. A certificate of analysis (CoA) describes one batch at one point in time, which is why the lot number on the document and the lot number printed on the vial must match. The anatomy of that document is set out in our guide on how to read a peptide CoA. An SDS carries none of the documentary properties that make a result checkable, which is why it sits outside the criteria used in our scoring methodology.
How does an SDS differ from a certificate of analysis?
The clearest way to hold the two apart is to ask, for each document, what it describes and who produced it.
| Question | Safety data sheet (SDS) | Certificate of analysis (CoA) |
|---|---|---|
| Who is the intended reader? | Handlers, shippers, emergency responders | The purchaser or quality reviewer of a specific batch |
| What does it describe? | A substance in general, and its hazards | One batch, as measured on a stated date |
| Is it batch specific? | No, it is reused across all lots | Yes, it is tied to a lot number |
| Who produces it? | The supplier or manufacturer | A testing laboratory, ideally named and independent |
| Does it contain instrument evidence? | No | Yes, when a chromatogram or spectrum is attached |
| Can it be verified at the source? | Not applicable | Yes, when a code resolves on the laboratory's own domain |
The two documents are complements, not substitutes. A vendor that publishes an SDS is doing something reasonable and useful. The failure mode is substitution: offering the hazard document in the place where batch evidence belongs.
Can an SDS tell you whether a peptide is pure or correctly identified?
No, and the reason is worth stating precisely, because identity and purity answer different questions. Purity is measured by high-performance liquid chromatography (HPLC), which separates a sample into peaks and reports the target peak as a percentage of total peak area, for example 99.0%. The chromatogram, meaning the plotted trace behind that number, is the real evidence. A bare percentage with no chromatogram behind it is a weak signal.
Identity is confirmed by mass spectrometry (MS, or LC-MS), which measures molecular mass to verify that the compound is the peptide claimed rather than merely one clean unknown substance. A sample can be 99% pure and still be the wrong molecule, and MS is what rules that out. A separate figure, net peptide content by amino acid analysis (AAA) or nitrogen determination, accounts for water, salts such as trifluoroacetate (TFA) or acetate, and counter-ions. An SDS reports none of these. It restates the intended identity, it does not test it. Our guide on HPLC versus mass spectrometry develops the comparison.
Does an SDS say anything about sterility or endotoxin levels?
It does not. Endotoxins, which are bacterial lipopolysaccharides, are measured by the Limulus Amebocyte Lysate (LAL) assay and reported in endotoxin units per milligram (EU/mg) or per millilitre (EU/mL). Sterility testing, which detects viable microorganisms, is a separate test entirely: passing one does not imply the other. The relevant compendial chapters are USP <85> for bacterial endotoxins and USP <71> for sterility.
Notice what this also means for certificates. A standard peptide purity and identity CoA usually does not include sterility or endotoxin data either, and that absence is common and ordinary. It must not be read as a sterility guarantee. The wider point is that neither document licenses a safety conclusion: a purity CoA describes composition, and an SDS describes hazard classification and handling precautions. Neither describes the microbiological state of a particular vial.
How do vendors sometimes present an SDS as a test result?
Publishing an SDS is good practice, so the issue is placement rather than the document itself. These are the patterns worth recognising when you are scanning a product page for evidence:
- A tab labelled with something like lab documents or testing that contains only an SDS.
- An SDS filed under a heading such as third party tested, when no third party laboratory is named anywhere on the page.
- An SDS supplied in response to a request for the CoA of a specific lot.
- A document carrying only the vendor's own letterhead, presented as external validation.
- An SDS with a purity figure typed into it, with no chromatogram, no lot number and no analysis date.
None of this requires bad intent to happen. A technical looking PDF satisfies a quick visual check, and the reader stops looking. The habit that protects you is to ask three questions of any document: what was measured, when, and which laboratory signed for it.
What should you ask for instead, and how is this scored?
Ask for the document that answers the question you actually have, which is a batch level CoA. A credible one shows:
- A named laboratory, independent of the vendor, rather than a phrase such as "tested by a US lab".
- A lot number on the document that matches the number printed on the vial.
- A date of analysis, because results describe a batch at a point in time.
- The chromatogram, and where identity is claimed, the mass spectrometry data: a chromatogram, not just a number.
- A verification mechanism, meaning a code or QR that resolves on the laboratory's own domain rather than a PDF hosted only by the vendor.
- ISO/IEC 17025 accreditation, the standard for testing laboratory competence, where the laboratory holds it.
Those are the properties the PeptideTrust scorecard measures, and you can apply the checklist yourself against the ranked transparency scoreboard. An SDS neither helps nor hurts a score; it is simply answering a different question. Transparency is a documentary property, not a marketing claim.
This guide is educational and describes documentary practice only. Research peptides are supplied for research use only. Nothing here is medical advice, and no document discussed, including a certificate of analysis, establishes that any substance is safe for use in humans or animals.